Valuation : Yuhan Corporation

Market Cap 6,168B 4.46B 3.83B 3.59B 3.29B 6.19B 426B 6.21B 42.49B 16.61B 215B 16.76B 16.4B 711B P/E 2026 *
41.5x
P/E 2027 * 30.1x
Enterprise Value 6.09B 4.41M 3.78M 3.54M 3.24M 6.11M 421M 6.13M 41.93M 16.39M 212M 16.54M 16.19M 702M EV / Sales 2026 *
2.6x
EV / Sales 2027 * 2.35x
Free-Float
64.28%
Yield 2026 *
0.69%
Yield 2027 * 0.69%
1 day-1.19%
1 week+4.65%
Current month+13.33%
1 month+11.21%
3 months-5.66%
6 months-26.35%
Current year-25.89%
1 week 80,700
Extreme 80700
84,700
1 month 68,500
Extreme 68500
87,500
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 19/03/2021
Director of Finance/CFO 58 -
President 67 15/03/2024
Director TitleAgeSince
Chairman 74 19/03/2021
Director/Board Member 71 20/03/2015
Director/Board Member 62 01/03/2020
Date Insider Type Main position Quantity % Market Cap.
30/06/25 Buy

Chairperson

200 0.0002%
25/06/25 Buy

Chief Executive Officer

720 0.0009%
24/06/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%+4.65%-28.68%+15.69% 4.46B
-2.33%+0.37%+77.88%+35.69% 369B
+0.05%+1.85%+30.64%-13.33% 70.96B
-0.13%+0.75%+46.11%+150.46% 12.14B
+1.74%+2.86%+3.80%+1.10% 8.6B
-2.31%-0.94%-16.02%-0.35% 4.99B
+1.34%-11.74%-32.42%+8.76% 3.22B
-1.54%-6.87%-1.95%+40.78% 2.57B
+2.75%-4.05%-15.05%-3.95% 2.2B
+0.08%+4.61%+262.67%+1,186.86% 1.79B
Average +0.08%-0.15%+32.70%+142.17% 47.99B
Weighted average by Cap. -0.01%+0.50%+65.89%+34.12%

Financials

2026 *2027 *
Net sales 2,340B 1.69B 1.45B 1.36B 1.25B 2.35B 162B 2.35B 16.12B 6.3B 81.53B 6.36B 6.22B 270B 2,556B 1.85B 1.59B 1.49B 1.36B 2.56B 177B 2.57B 17.6B 6.88B 89.03B 6.94B 6.79B 295B
Net income 154B 111M 95.51M 89.42M 81.88M 154M 10.63B 155M 1.06B 414M 5.36B 418M 409M 17.73B 206B 149M 128M 120M 110M 207M 14.24B 207M 1.42B 555M 7.18B 560M 548M 23.75B
Net Debt -80.13B -58M -49.79M -46.61M -42.68M -80.4M -5.54B -80.63M -552M -216M -2.79B -218M -213M -9.24B -162B -117M -101M -94.13M -86.19M -162M -11.19B -163M -1.11B -436M -5.64B -440M -430M -18.66B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
27/08/26 ₩82,700.00 -4.61% 376,123
26/08/26 ₩86,700.00 +4.08% 314,903
25/08/26 ₩83,300.00 -1.19% 178,548
24/08/26 ₩84,300.00 +2.43% 239,672
21/08/26 ₩82,300.00 -1.32% 266,255
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
82,700.00KRW
Average target price
120,111.11KRW
Spread / Average Target
+45.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock